What do you get out of GCMI’s Phase Zero?

Fast track answers to critical questions that de-risk medtech innovations   When an innovator has identified a medical problem, taking an efficient approach to minimize risk and identify the viability of potential solutions is key. Our Phase Zero focuses on evaluating critical product elements early, minimizing risk, cost and effort.    Key questions: What is…

How GCMI helps Georgia Tech faculty members convert research into innovative medical products – Our one-on-one interview with Dr. Omer Inan

GCMI’s foremost goal as an affiliate of the Georgia Institute of Technology is to partner with Georgia Tech faculty and engineers in the innovation process of new medical products. One successful example of this partnership has been our work with Dr. Scott Hollister. With GCMI’s help, Children’s Healthcare of Atlanta surgeons used Dr. Hollister’s process…

Need help moving a medtech device through development and regulatory pathways? Connect with T3 Labs at ASAIO 2019.

At GCMI, medtech and medical device innovation are at the core of our efforts including our work within our industry leading preclinical CRO. While our team constantly focuses on the advancement of our sponsors’ journeys from concept to commercialization to cure, we actively seek to attend events that connect us with medtech innovators across the…

Commercializing Research to Reengineer Healthcare as We Know It

  GCMI’s 2018 year end review and 2019 look ahead Thanks to our staff, customers, sponsors and fellow industry, academic and philanthropic visionaries, GCMI has tangibly advanced our mission of accelerating the development, testing, training and commercialization of innovative medical products that improve quality based outcomes and delivery of healthcare for patients. 2018 Highlights Leading…